Open AccessCombination of Performance Status and Lymphocyte-monocyte Ratio as a Novel Prognostic Marker for Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Author(s) -
Jun Aoyama,
Tatsu Kuwahara,
Daisuke Sano,
Takuo Fujisawa,
Motohiko Tokuhisa,
Minaki Shimizu,
Tomofumi Sakagami,
Yasushi Ichikawa,
Hiroshi Iwai,
Nobuhiko Oridate
Publication year - 2021
Publication title -
cancer diagnosis and prognosis
Language(s) - English
Resource type - Journals
ISSN - 2732-7787
DOI - 10.21873/cdp.10047
Subject(s) - medicine , regimen , oncology , proportional hazards model , multivariate analysis , head and neck squamous cell carcinoma , retrospective cohort study , head and neck cancer , performance status , radiation therapy , cancer
We previously presented the real-world treatment outcomes of the EXTREME regimen as a first-line therapy for recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). This study aimed to evaluate the prognostic significance of pretreatment inflammatory biomarkers in patients with R/M-SCCHN treated with the EXTREME regimen as first-line therapy as a supplementary study of our previous retrospective cohort study.